4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-017343
Head of R&D, CSO gave up 1,216 shares (to pay taxes)
- Head of R&D, CSO acquired 8,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rodino-Klapac Louise · Head of R&D, CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-04 | Shares withheld for taxes : show line 1 in the form | −1,216 | $79.20 | $96,307 | 64,111 | D |
| 2022-03-07 | Grant or award : show line 2 in the form | +8,000 | 72,111 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-07 | Grant or award : show line 3 in the form Stock Option (right to buy) | +48,000 | 48,000 | D |
Loading xslF345X03/doc4.xml…